Chlamydia STD
Conditions
Interventions
None listed
Sponsors
Roche Molecular Systems (RMS)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Suspected for STD
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The statistical analyses will be performed separately for each type of specimen. The positive correlation, negative correlation and overall agreement (total concordance) of the cobas 4800 CT/NG Test to the Abbott m2000 CT/NG Test will be calculated along with the 95% confidence intervals. Calculations will be done with initial results as well as final resolved results. The cobas 4800 CT/NG Test and the Abbott m2000 CT/NG Test shall be considered equivalent by having the exact 95% (one-sided) confidence bound for percent Chlamydia trachomatis positive specimen greater than 90%. The cobas 4800 CT/NG Test and the Abbott m2000 CT/NG Test shall be considered equivalent by having the exact 95% (one-sided) confidence bound for percent Neisseria gonorrhoeae positive specimen greater than 90%. In the event that the final samples sizes for the endocervical swab CT and/or NG positive specimens falls below 50, an overall cobas 4800 CT/NG Test positive correlation of at least 95% must be met for both CT and NG to show equivalence to the Abbott m2000 CT/NG Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| n.a. | — |
Countries
Netherlands
Outcome results
None listed